Zevia's Q2: $45 Million in Sales, but the Turnaround Case Still Rests on Pricing

Q2 Sales Grew, but Price Did Most of the Work

Pricing offset softer volume

Zevia posted $45.0 million in Q2 net sales, up 1.1% year over year. That headline was stable, but the mix underneath was less reassuring: pricing offset a 3.7% volume decline. In other words, the quarter was lifted mainly by higher prices, not by materially stronger demand. That distinction matters. Price can support one quarter; durable growth usually has to come from volume.

Management also linked the prior-year volume comparison to distribution load-ins, which adds another reason not to read this result as a clean demand recovery.

Adjusted EBITDA improved, but GAAP profit worsened

Adjusted EBITDA improved to about $0.5 million from the prior year. But GAAP profitability slipped, with a net loss of $2.91 million, or $0.04 diluted loss per share. The gap helps explain the mixed read on the quarter: adjusted metrics look better, while the reported income statement still shows how fragile the margin profile remains.

Gross margin only edged up to 48.9%, and higher aluminum costs continued to pressure the model. The takeaway is straightforward: Zevia still needs better operating leverage if pricing is no longer going to do all the heavy lifting.

The Turnaround Story Still Has Time on Its Side

Management is asking investors to look beyond one quarter. Zevia reported 10.4% first-half net sales growth, and the balance sheet still provides room to execute. The company ended the quarter with about $28.5 million in cash and an undrawn $20 million credit line. For a business of this size, that liquidity matters. It reduces the risk that a turnaround attempt gets derailed by financing stress.

Cash flow gives management more room

Zevia generated positive free cash flow of $2.19 million in Q2, compared with negative free cash flow a year earlier. That does not prove demand has recovered, but it does suggest the business is generating more cash from operations than it was.

Management's Q3 2026 net sales guidance of $44 million to $46 million is consistent with a steady quarter, not a sharp acceleration. Bulls can fairly argue that one weak-volume quarter is not enough to conclude the brand has lost momentum.

Operating discipline is improving, but the full-year math is still tight

Some operating trends looked healthier. Selling expense fell to 17.9% of net sales, while marketing expense rose to 11.1% of net sales. That suggests a somewhat more disciplined spending mix rather than a blunt cost cut.

The bigger issue is the full-year outlook. Management maintained 2026 net sales guidance of $170 million to $175 million and adjusted EBITDA guidance of a $2 million to $4 million loss. At the same time, full-year 2026 revenue expectations rose, while full-year 2026 EPS expectations worsened from $-0.11 to $-0.16.

That is the core bull-bear split. Revenue expectations moving higher while earnings expectations move lower means investors still need proof that growth is getting cleaner, not just more expensive.

What to watch in the next few quarters

• Does adjusted EBITDA improve, or does the company remain stuck near breakeven?
• Does marketing spend stay elevated while selling expense remains disciplined?
• Does the earnings outlook stabilize as revenue builds?

If Zevia can grow sales without profitability deteriorating further, the stock has a case to rerate. If not, investors may just be funding a slower repair job.

What Would Strengthen the Investment Case

Zevia does not need a perfect quarter to become interesting again. It needs evidence that it can add revenue without leaning too heavily on price, and then convert some of that revenue into a wider profit lane. The improved cash flow helps, but cash generation alone is not the same as durable demand. For now, this still looks more like a watchlist story than a conviction buy.

Bull trigger: savings have to show up in margins

The cleaner catalyst is simple: expected cost savings need to show up in reported margins, not just in management commentary. If those savings improve operating leverage, the business becomes easier to underwrite. If not, the turnaround case stays dependent on optimism rather than results.

What would weaken the case

The setup weakens if cost savings slip, volume stays soft, full-year adjusted EBITDA guidance remains deep in the red, and expense discipline starts to drift. In that outcome, the story would be lasting longer than the numbers justify.

Until volume and operating leverage improve together, ZVIA still looks like a turnaround to monitor, not a turn-and-run buy.